Skip to main content
Clinical Trials/NCT06266585
NCT06266585
Completed
N/A

Risk Factor Analysis and Development of a Predictive Model for Clinical Deterioration During Hospitalization in Patients With Cerebral Venous Thrombosis

Beijing Tiantan Hospital1 site in 1 country273 target enrollmentJanuary 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebral Venous Thrombosis
Sponsor
Beijing Tiantan Hospital
Enrollment
273
Locations
1
Primary Endpoint
Number of Participants with CVT deteriorated on radiology
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this retrospective, prospective, multicenter cohort study is to determine the risk factors for deterioration of CVT patients after admission and establish a scoring model for risk stratification of patients. This study included two stages, the first stage was to enroll CVT patients from a single center from 2017 to 2022 for modeling, and the second stage was to enroll CVT patients from three centers in 2023 for external validation

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
January 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Tiantan Hospital
Responsible Party
Principal Investigator
Principal Investigator

Wang Shuo

Director of Department of cerebrovascular Neurosurgery

Beijing Tiantan Hospital

Eligibility Criteria

Inclusion Criteria

  • Age≥ 18 years old
  • Patients were diagnosed with cerebral venous thrombosis (CVT) through imaging techniques such as Computed Tomography Venography (CTV), Magnetic Resonance Venography (MRV), or Digital Subtraction Angiography (DSA)
  • The diagnostic algorithm for CVT conformed to the current guideline criteria

Exclusion Criteria

  • Patients who had performed endovascular treatment (EVT) or decompressive craniectomy (DC) before admission and those whose primary treatment was EVT or DC rather than conservative treatment after admission
  • Patients with severe hepatic or renal insufficiency
  • Patients with intracranial tumors
  • Patients with other cerebrovascular diseases

Outcomes

Primary Outcomes

Number of Participants with CVT deteriorated on radiology

Time Frame: After admission until discharge, a maximum of 30 days

One of the following situations occurs: new or progressive bleeding or infarction, midline displacement (\>3mm), increased cerebral edema, and placeholder effect by comparing the CT before and after; mRS and/or GCS decreased due to decreased consciousness, increased focal neurological impairment, new focal neurological impairment or death.

Number of Participants with altered neurological function

Time Frame: After admission until discharge, a maximum of 30 days

mRS Score decreased due to decreased consciousness, increased focal neurological impairment, new focal neurological impairment or death.

Number of Participants with altered consciousness

Time Frame: After admission until discharge, a maximum of 30 days

GCS Score decreased

Secondary Outcomes

  • Emergency surgery rates(After admission until discharge, a maximum of 30 days)
  • Neurological function at 30th day after onset (mRS)(30th day after onset)

Study Sites (1)

Loading locations...

Similar Trials